rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE

Novartis India Ltd.

500672 NOVARTIND Group (B)

19 Mar,15:46
767.00
18.05 (2.41%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Novartis India Ltd.

BUYSELL

34,017 748.95 786.00 - 749.85 1,248.00 - 744.95 1,894.50

is not listed on NSE (View BSE)

News for Novartis India Ltd.

Eli Lilly Appoints Winselow Tucker to Lead India Operations
Eli Lilly has appointed Winselow Tucker as President and General Manager for India, effective immediately. Tucker will lead all of Lilly's operations in India, including the Lilly India commercial...
Feb 04, 2025 11:42
Natco Pharma Gets...
Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets
Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for patients with tuberous sclerosis complex. The drug is a generic version of...
Jan 30, 2025 11:36
Claypond Capital...
Claypond Capital Appoints Shravan Subramanyam for MedTech Platform
Claypond Capital, the family investment office of Manipal Group chairman Ranjan Pai, has hired Shravan Subramanyam, former MD of Wipro-GE Healthcare, to lead its medical technology platform.
Jan 02, 2025 21:45
AI & Machine...
AI & Machine Learning: Transforming Indian Pharma by 2025
India's pharmaceutical industry is poised for a dramatic transformation by 2025, driven by AI, machine learning, and precision medicine. Discover how innovation, global access, and quality...
Dec 26, 2024 11:20
Aurobindo Pharma...
Aurobindo Pharma Gets USFDA Approval for Generic Cancer Drug
Aurobindo Pharma's subsidiary, Eugia Pharma Specialities, has received USFDA approval to market Pazopanib Tablets (200 mg) in the US. The drug is therapeutically equivalent to Novartis' Votrient...
Dec 05, 2024 16:30

More News for Novartis India Ltd. »

(Rs. Crore)

Financial Results of Novartis India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales335.07378.74399.87381.35438.25
Operating profit65.2665.0827.1126.7912.03
Interest1.491.754.837.686.39
Gross profit125.45121.4455.4752.2041.78
EPS (Rs)34.5241.88-1.518.474.08

See more in Research Center »

News for Pharmaceuticals and health care

Vageshwari...
Vageshwari Properties Buys Rs 276 Crore Bungalow in Mumbai
Vageshwari Properties has purchased a historic bungalow at Malabar Hill in Mumbai for Rs 276 crore. The property, known as Laxmi Nivas, was a secret hideout for freedom fighters during the Quit...
Mar 19, 2025 23:29
Telangana GSDP...
Telangana GSDP Surges 10% to Rs 16 Lakh Cr in FY25
Telangana's economy grew by 10% in FY25, with GSDP reaching Rs 16.12 lakh crore. The state's per capita income also saw significant growth, driven by strong performance in the IT sector and...
Mar 19, 2025 22:53
FDI Limit in...
FDI Limit in Insurance: Parliament Panel Urges Safeguard Measures
A Parliamentary panel has urged the government to implement safeguard measures before raising the FDI limit to 100% in the insurance sector, citing concerns like profit repatriation and job security.
Mar 19, 2025 22:44
India-NZ PM...
India-NZ PM Talks: Deepening 'Special Relationship' & Trade Deal - PTI
New Zealand Prime Minister Christopher Luxon expresses desire to deepen ties with India, emphasizing tourism and education collaboration. A free trade agreement is expected in the next two months.
Mar 19, 2025 22:33
IBBI Mandates...
IBBI Mandates Carry-Forward Loss Disclosure in Insolvency
The IBBI has made it mandatory for insolvency professionals to disclose carry-forward losses in the Information Memorandum during the insolvency process. This aims to provide potential resolution...
Mar 19, 2025 22:26

More News »

Top News

EU, India Counterterrorism Experts Exchange Best Practices
EU and Indian counterterrorism experts met in New Delhi to exchange best practices on preventing and countering violent extremism, focusing on de-radicalization, rehabilitation, and...
Mar 20, 2025 00:01
Vageshwari...
Vageshwari Properties Buys Rs 276 Crore Bungalow in Mumbai
Vageshwari Properties has purchased a historic bungalow at Malabar Hill in Mumbai for Rs 276 crore. The property, known as Laxmi Nivas, was a secret hideout for freedom fighters during the Quit...
Mar 19, 2025 23:29
Telangana GSDP...
Telangana GSDP Surges 10% to Rs 16 Lakh Cr in FY25
Telangana's economy grew by 10% in FY25, with GSDP reaching Rs 16.12 lakh crore. The state's per capita income also saw significant growth, driven by strong performance in the IT sector and...
Mar 19, 2025 22:53
FDI Limit in...
FDI Limit in Insurance: Parliament Panel Urges Safeguard Measures
A Parliamentary panel has urged the government to implement safeguard measures before raising the FDI limit to 100% in the insurance sector, citing concerns like profit repatriation and job security.
Mar 19, 2025 22:44
SBFC Finance Promoter Sells 1.3% Stake for Rs 112 Crore
SBFC Holdings Pte, a promoter of SBFC Finance, divested a 1.3% stake in the company for Rs 112 crore through an open market transaction. The shares were sold at an average price of Rs 82 apiece.
Mar 19, 2025 22:36

More Top News »

Report Card

PE Ratios
22.22
EPS (Rs.)
34.52
Sales (Rs. Cr)
93.00
Face Value (Rs.)
5
Net Profit Margin (%)
25.42
Last Bonus
1:2
Last Dividend(%)
500
Return on Average Equity
11.43

Compare 'Novartis India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,748.60
  • Compare
  • Divi's Laboratories Ltd.
  • 5,777.90
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,164.70
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,135.60
  • Compare
  • Zydus Lifesciences Ltd.
  • 903.10
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,017.45
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,249.50
  • Compare

Novartis India Ltd. performance snapshot

If you had invested Rs.  in Novartis India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add Novartis India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Novartis India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close